If you have been recently diagnosed with non-small cell lung cancer (NSCLC), please know you’re not alone. This website provides information about clinical trials for adults with NSCLC. NSCLC is the most common type of lung cancer in the US, accounting for 84% of all lung cancer diagnoses, with 75% of these cases diagnosed in advanced stage.
Clinical trials are essential to investigating potential treatments and are not possible without the patients who take part. Everyone involved in this clinical trial plays an important role in increasing our understanding of NSCLC, which may help other patients in the future with this condition.
We understand you may feel overwhelmed with your recent diagnosis of NSCLC and already have enough to do without joining a clinical trial. However, your participation in this trial may play a key role in helping to develop new therapies for patients with NSCLC. Every treatment that exists today was made possible by trial participants who actively took part in research.
Learn more about Regeneron NSCLC trials and see if they may be an option for you.
Empower Vax L-1
Developing potential treatments for people with advanced NSCLC.
See if you may be eligible >
Harmony Lung-1
Developing potential NSCLC treatments for smokers or people who have previously smoked.
See if you may be eligible >
Harmony Lung-2
Testing the safety and efficacy of an investigational treatment combination for advanced NSCLC.
See if you may be eligible >
Harmony Peri-Operative Lung
Developing potential treatments for operable NSCLC.
See if you may be eligible >
Harmony Peri-Operative Lung
Developing potential treatments for operable NSCLC.
See if you may be eligible >
Empower-Vax Lung 1
Developing potential treatments for people with advanced NSCLC.
See if you may be eligible >
Find a study site near you
To find your nearest study site, please enter your zip code.
English 
Spanish (United States) 
Spanish (Spain) 
German 
Georgian